Reiterová J, Safránková H, Obeidová L, Stěkrová J, Maixnerová D, Merta M, Tesař V
Department of Nephrology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
Folia Biol (Praha). 2012;58(2):64-8.
Focal segmental glomerulosclerosis and minimal change disease represent frequent histological patterns of renal injury in patients with nephrotic syndrome. Few cases carrying NPHS2 gene variants have been described to date. Mutational analysis of the NPHS2 gene was performed in 50 Czech adult patients with histologically proved FSGS/MCD. The common p.P20L and p.R229Q polymorphisms of the NPHS2 gene were tested in 169 patients with IgA nephropathy and in 300 individuals of the control group. No mutation in the NPHS2 gene in patients with adult onset was identified. One homozygous mutation p.V290M in a patient with onset in early childhood was found. One new heterozygous variant in the non-conservative area of the NPHS2 gene, p.G97S, was identified in a patient with childhood-onset FSGS. In one adult patient, there were two polymorphisms, p.P20L and p.R229Q, in trans-heterozygous state, which could contribute to steroid-resistant nephrotic syndrome. The most common polymorphism p.R229Q was identified in 12 % of FSGS/ MCD patients, in 11.8 % of IGAN patients and in 10% of controls. The heterozygosity of p.R229Q polymorphism was similar in the IGAN group, with non-significantly higher prevalence in IGAN patients with progressive form of the disease (15.9 % versus 9.4 %). The prevalence of p.P20L polymorphism was not significantly different among the groups (6 % in FSGS patients, 1.8 % in IGAN patients, 1 % in the control group). To conclude, NPHS2 mutations are rare in patients with adult onset of FSGS/MCD. The R229Q polymorphism is frequent in the Czech population and probably could have some influence on IGAN.
局灶节段性肾小球硬化和微小病变病是肾病综合征患者常见的肾脏损伤组织学类型。迄今为止,仅有少数携带NPHS2基因变异的病例被报道。对50例经组织学证实为FSGS/MCD的捷克成年患者进行了NPHS2基因的突变分析。在169例IgA肾病患者和300例对照组个体中检测了NPHS2基因常见的p.P20L和p.R229Q多态性。未在成年发病患者中鉴定出NPHS2基因突变。在一名儿童期起病的患者中发现了一个纯合突变p.V290M。在一名儿童期起病的FSGS患者中鉴定出NPHS2基因非保守区域的一个新的杂合变异p.G97S。在一名成年患者中,发现了处于反式杂合状态的两个多态性p.P20L和p.R229Q,这可能导致激素抵抗型肾病综合征。最常见的多态性p.R229Q在12%的FSGS/MCD患者、11.8%的IgA肾病患者和10%的对照组个体中被鉴定出。p.R229Q多态性的杂合性在IgA肾病组中相似,在疾病进展型的IgA肾病患者中患病率略高但无显著差异(15.9%对9.4%)。p.P20L多态性的患病率在各组之间无显著差异(FSGS患者中为6%,IgA肾病患者中为1.8%,对照组中为1%)。总之,NPHS2突变在成年起病的FSGS/MCD患者中罕见。R229Q多态性在捷克人群中常见,可能对IgA肾病有一定影响。